Zoetis Inc
NYSE:ZTS

Watchlist Manager
Zoetis Inc Logo
Zoetis Inc
NYSE:ZTS
Watchlist
Price: 176.96 USD 0.14% Market Closed
Market Cap: 79.8B USD
Have any thoughts about
Zoetis Inc?
Write Note

Relative Value

The Relative Value of one ZTS stock under the Base Case scenario is 142.63 USD. Compared to the current market price of 176.96 USD, Zoetis Inc is Overvalued by 19%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ZTS Relative Value
Base Case
142.63 USD
Overvaluation 19%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
90
vs Industry
16
Median 3Y
9.6
Median 5Y
10.1
Industry
2.5
Forward
8.6
vs History
88
vs Industry
13
Median 3Y
36.8
Median 5Y
39.5
Industry
21.9
Forward
29.9
vs History
98
vs Industry
13
Median 3Y
37.6
Median 5Y
37.1
Industry
16.5
vs History
79
vs Industry
11
Median 3Y
63.8
Median 5Y
55.4
Industry
23.6
vs History
90
vs Industry
4
Median 3Y
17.1
Median 5Y
18.5
Industry
2.1
vs History
88
vs Industry
13
Median 3Y
10.1
Median 5Y
10.6
Industry
2.6
Forward
9.1
vs History
88
vs Industry
13
Median 3Y
14.4
Median 5Y
15.3
Industry
5.2
vs History
90
vs Industry
15
Median 3Y
24.1
Median 5Y
25.9
Industry
13.3
Forward
21.2
vs History
92
vs Industry
16
Median 3Y
27.9
Median 5Y
30.2
Industry
16.6
Forward
24
vs History
98
vs Industry
12
Median 3Y
39.7
Median 5Y
38.7
Industry
15.6
vs History
98
vs Industry
9
Median 3Y
56.3
Median 5Y
52.8
Industry
19.1
vs History
77
vs Industry
13
Median 3Y
7.4
Median 5Y
7.6
Industry
1.9

Multiples Across Competitors

ZTS Competitors Multiples
Zoetis Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Zoetis Inc
NYSE:ZTS
79.9B USD 8.7 32.9 22.1 25.4
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
US
Zoetis Inc
NYSE:ZTS
Average P/E: 32.5
32.9
38%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top